Use and Eligibility for Glucose-Like Peptide-1 Receptor Agonist Treatment for Primary Prevention of Stroke
{{output}}
Objectives: The 2024 American Heart Association and American Stroke Association stroke prevention guideline newly recommended glucose-like peptide-1 receptor agonists (GLP-1s) for primary prevention of stroke in patients with dia... ...
